Allen Wealth Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.64M Sell
9,958
-802
-7% -$212K 1.28% 13
2026
Q2
$2.73M Sell
10,760
-785
-7% -$183K 1.33% 15
2026
Q1
$2.82M Buy
11,545
+104
+0.9% +$24.2K 1.41% 13
2025
Q4
$2.37M Buy
11,441
+514
+5% +$102K 1.42% 16
2025
Q3
$2.03M Buy
10,927
+7,867
+257% +$1.35M 1.37% 16
2025
Q2
$467K Sell
3,060
-100
-3% -$15.4K 0.33% 40
2025
Q1
$524K Hold
3,160
– – 0.36% 39
2024
Q4
$457K Sell
3,160
-407
-11% -$63.1K 0.33% 41
2024
Q3
$578K Buy
3,567
+100
+3% +$15.9K 0.4% 38
2024
Q2
$507K Sell
3,467
-21
-0.6% -$3.12K 0.45% 39
2024
Q1
$552K Buy
3,488
+14
+0.4% +$2.23K 0.49% 38
2023
Q4
$545K Buy
+3,474
New +$533K 0.53% 34

Other funds holding JNJ

Allen Wealth Management's JNJ Position: Q3 2026 in Review

Allen Wealth Management reduced its Johnson & Johnson (JNJ) stake by 7.5% in Q3 2026, selling an estimated $212K and leaving 9,958 shares worth $2.64M. The position accounts for 1.28% of the portfolio, ranked #13.

Allen Wealth Management first reported a position in JNJ in Q4 2023 and has held it in 12 quarters since. The position peaked at $2.82M in Q1 2026. 3,684 funds tracked by Wall St. Rank hold JNJ as of Q3 2026.

  • Allen Wealth Management held 9,958 shares of Johnson & Johnson worth $2.64M as of Q3 2026.
  • Allen Wealth Management sold 802 Johnson & Johnson shares in Q3 2026, an estimated $212K.
  • Johnson & Johnson made up 1.28% of Allen Wealth Management's portfolio in Q3 2026, its #13 holding.
  • Allen Wealth Management first reported a position in Johnson & Johnson in Q4 2023 and has held it in 12 quarters since.
  • Allen Wealth Management's Johnson & Johnson position peaked at $2.82M in Q1 2026.
  • 3,684 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2026.

Based on Allen Wealth Management's 13F filing for Q3 2026, filed 29 Oct 2026.